share_log

Curaleaf Holdings Analyst Ratings

Benzinga ·  Aug 10, 2023 05:55
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
08/10/2023 39.34% Needham → $4.25 Reiterates Buy → Buy
05/19/2023 47.54% Wedbush → $4.5 Reiterates Outperform → Outperform
05/19/2023 Benchmark Downgrades Buy → Hold
05/18/2023 39.34% Needham → $4.25 Reiterates Buy → Buy
05/02/2023 39.34% Needham $5 → $4.25 Maintains Buy
04/14/2023 162.3% Alliance Global Partners $11 → $8 Maintains Buy
04/14/2023 178.69% Wedbush → $8.5 Reiterates → Outperform
12/30/2022 293.44% Cantor Fitzgerald $13 → $12 Maintains Overweight
12/02/2022 178.69% Wedbush → $8.5 Initiates Coverage On → Outperform
11/08/2022 326.23% Cantor Fitzgerald $13.5 → $13 Maintains Overweight
10/28/2022 342.62% Cantor Fitzgerald $13.7 → $13.5 Maintains Overweight
08/09/2022 349.18% Cantor Fitzgerald $14.6 → $13.7 Maintains Overweight
07/22/2022 195.08% Seaport Global → $9 Initiates Coverage On → Buy
05/10/2022 378.69% Cantor Fitzgerald $16.5 → $14.6 Maintains Overweight
05/10/2022 227.87% Needham $15 → $10 Maintains Buy
04/25/2022 440.98% Cantor Fitzgerald $15.5 → $16.5 Maintains Overweight
03/04/2022 391.8% Needham $17 → $15 Maintains Buy
03/04/2022 408.2% Cantor Fitzgerald $16.5 → $15.5 Maintains Overweight
01/07/2022 Wolfe Research Initiates Coverage On → Peer Perform
01/04/2022 440.98% Cantor Fitzgerald $18.5 → $16.5 Maintains Overweight
11/03/2021 555.74% Cantor Fitzgerald $24 → $20 Maintains Overweight
10/08/2021 522.95% Needham $19.75 → $19 Maintains Buy
03/10/2021 768.85% Cantor Fitzgerald $23.5 → $26.5 Maintains Overweight
03/10/2021 547.54% Needham $18.5 → $19.75 Maintains Buy
01/20/2021 555.74% Roth Capital $14 → $20 Maintains Buy
01/20/2021 670.49% Cantor Fitzgerald $20 → $23.5 Maintains Overweight
11/18/2020 359.02% Needham $13.5 → $14 Maintains Buy
11/18/2020 555.74% Cantor Fitzgerald $18 → $20 Maintains Overweight
08/18/2020 342.62% Needham $11 → $13.5 Maintains Buy
08/18/2020 490.16% Cantor Fitzgerald → $18 Upgrades Neutral → Overweight
08/06/2020 260.66% Needham $10.7 → $11 Maintains Buy
08/04/2020 227.87% Cantor Fitzgerald $7.5 → $10 Maintains Neutral
05/19/2020 145.9% Cantor Fitzgerald $6 → $7.5 Maintains Neutral
05/19/2020 231.15% Needham $5.9 → $10.1 Maintains Buy
05/12/2020 93.44% Needham $5.5 → $5.9 Maintains Buy
03/25/2020 54.1% Cantor Fitzgerald $4.1 → $4.7 Reiterates → Neutral
02/14/2020 181.97% Cantor Fitzgerald → $8.6 Initiates Coverage On → Neutral
12/03/2019 137.7% Needham → $7.25 Initiates Coverage On → Buy
09/20/2019 63.93% MKM Partners → $5 Initiates Coverage On → Sell
06/11/2019 Compass Point Initiates Coverage On → Buy

What is the target price for Curaleaf Holdings (CURLF)?

The latest price target for Curaleaf Holdings (OTCQX: CURLF) was reported by Needham on August 10, 2023. The analyst firm set a price target for $4.25 expecting CURLF to rise to within 12 months (a possible 39.34% upside). 11 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for Curaleaf Holdings (CURLF)?

The latest analyst rating for Curaleaf Holdings (OTCQX: CURLF) was provided by Needham, and Curaleaf Holdings reiterated their buy rating.

When is the next analyst rating going to be posted or updated for Curaleaf Holdings (CURLF)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Curaleaf Holdings, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Curaleaf Holdings was filed on August 10, 2023 so you should expect the next rating to be made available sometime around August 10, 2024.

Is the Analyst Rating Curaleaf Holdings (CURLF) correct?

While ratings are subjective and will change, the latest Curaleaf Holdings (CURLF) rating was a reiterated with a price target of $0.00 to $4.25. The current price Curaleaf Holdings (CURLF) is trading at is $3.05, which is within the analyst's predicted range.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment